Original Research
Published on 04 Jan 2018
Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2017.01885
- 5,256 views
- 4 citations
